Thursday, November 12, 2026

GBP/EUR Bearish Momentum With A 2% Fall In The Last 21 Sessions

ViaNews Editorial Team

November 18, 2023

GBP/EUR Bearish Momentum With A 2% Fall In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 2.01% for the last 21 sessions. At 22:06 EST on Friday, 17 November, GBP/EUR (GBPEUR) is $1.14.

GBP/EUR's yearly highs and lows, it's 2.532% up from its 52-week low and 2.999% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.02%, a negative 0.04%, and a positive 0.19%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.22% (last week), 0.20% (last month), and 0.19% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy steadily climbs to 150.75-80 area, fresh daily high after weaker Japanese GDP. According to FXStreet on Wednesday, 15 November, "Apart from this, the risk-on mood is seen as another factor weighing on the safe-haven JPY, which, along with a modest US Dollar (USD) uptick, acts as a tailwind for the USD/JPY pair.", "The USD/JPY pair regains positive traction during the Asian session on Wednesday and reverses a part of the previous day's heavy losses to the 150.15 area, or a one-week low. "
  • Usd/jpy trades with modest intraday losses, manages to hold above 151.00 mark. According to FXStreet on Thursday, 16 November, "The US Dollar (USD) looks to build on the overnight recovery move from its lowest since September 1 amid the uncertainty over the Federal Reserve's (Fed) next policy move, which, in turn, should act as a tailwind for the USD/JPY pair. ", "The USD/JPY pair struggles to capitalize on the previous day's rally of around 140 pips from the 150.00 psychological mark, or over a one-week low and edges lower during the Asian session on Thursday. "
  • Usd/jpy rebounds above 151.00, on mixed US data, higher US bond yields. According to FXStreet on Thursday, 16 November, "On Wednesday, the USD/JPY trimmed some of Tuesday's more than 0.89% losses and climbed back above the 151.00 figure, after dropping to a weekly low of 150.15. "
  • Usd/jpy technical analysis: uptrend still intact - 15 November 2023. According to DailyForex on Wednesday, 15 November, "Even if Japanese authorities decide to intervene, as long as the Bank of Japan phases out yield curve control (YCC) in piecemeal steps and occasionally intervenes in the bond market to keep long-term yields below 1%, the USD/JPY uptrend may be destined to continue. ", "According to the performance on the daily chart below, the overall trend for the USD/JPY pair is still up, even though the US inflation data was negative. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com